Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0075 AUD | +7.14% | -6.25% | -6.25% |
Apr. 10 | Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment | MT |
Feb. 23 | Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 10
Sales per Business
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical Research and Development
100.0
%
| 1 | 100.0 % | 3 | 100.0 % | +149.08% |
Sales per region
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Australia
100.0
%
| 1 | 100.0 % | 3 | 100.0 % | +149.08% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Chief Tech/Sci/R&D Officer | - | 12-05-31 | |
Rebecca Tunstall
PRN | Corporate Officer/Principal | - | 22-05-15 |
Stefan Ross
SEC | Corporate Secretary | - | 21-10-28 |
Deanne Greenwood
PRN | Corporate Officer/Principal | - | 07-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Pamela Klein
BRD | Director/Board Member | 63 | 19-09-30 |
James Campbell
CEO | Chief Executive Officer | - | 14-11-11 |
Michael Stork
BRD | Director/Board Member | - | 07-02-18 |
Chairman | - | 22-11-15 | |
Stefan Ross
SEC | Corporate Secretary | - | 21-10-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,055,750,236 | 1,424,510,943 ( 69.29 %) | 0 | 69.29 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-6.25% | 9.61M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.54% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- PAB Stock
- Company Patrys Limited